Actavis’ Record-Breaking Quarterly Sales Show Success Of Merger Strategy

Strong quarter for generic Mycardis, Lidoderm and Cymbalta spurs 36% increase in pharma product sales, while businesses inherited from Warner Chilcott lead to exponential growth in North American branded product revenue. Firm is getting ready for integration of Forest around mid-year.

More from United States

More from North America